Development of a model for the homing of multiple myeloma cells to human bone marrow

Blood

Volumn 90, Issue 2, 1997, Pages 754-765

  Urashima, Mitsuyoshi ^b   Chen, Benjamin P ^b   Chen, Shirley ^b   Pinkus, Geraldine S ^b   Bronson, Roderick T ^b   Dedera, Douglas A ^b   Hoshi, Yasutaka ^b   Teoh, Gerrard ^b   Ogata, Atsushi ^b   Treon, Steve P ^b   Chauhan, Dharminder ^b   Anderson, Kenneth C ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; IMMUNOGLOBULIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW; CANCER IMMUNOLOGY; CELL ADHESION; CELL INFILTRATION; CELL SURVIVAL; CONTROLLED STUDY; HUMAN; HUMAN CELL; MOUSE; MULTIPLE MYELOMA; NONHUMAN; PRIORITY JOURNAL; SCID MOUSE;

EID: 0030746359     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.2.754     Document Type: Article

References (53)

1. Uchiyama H, Barut BA, Mohrbacher AF, Chauhan D, Anderson KC: Adhesion of human myeloma-derived cell lines to bone marrow stromal cells stimulates interleukin-6 secretion. Blood 82:3712, 1993
2. Chauhan D, Uchiyama H, Akbarali Y, Urashima M, Yamamoto KI, Libermann TA, Anderson KC: Multiple myeloma cell adhesion-induced interleukin-6 expression in bone marrow stromal cells involves activation of NF-κB. Blood 87:1104, 1996
3. Uchiyama H, Barut BA, Chauhan D, Cannistra SA, Anderson KC: Characterization of adhesion on human myeloma cell lines. Blood 80:2306, 1992
4. Ahsmann EJM, Lokhorst HM, Dekker AW, Bloem AC: Lymphocyte function-associated antigen-1 expression on plasma cells correlates with tumor growth in multiple myeloma. Blood 79:2068, 1992
5. Barille S, Collette M, Bataille R, Amiot M: Myeloma cells upregulate IL-6 but downregulate osteocalcin production by osteoblastic cells through cell contact. Blood 86:3141, 1995
6. Huang N, Kawano MM, Harada H, Harada Y, Sakai A, Kuramoto A, Niwa O: Heterogeneous expression of a novel MPC-1 antigen on myeloma cells: Possible involvement of MPC-1 antigen in the adhesion of mature myeloma cells to bone marrow stromal cells. Blood 82:3721, 1993
7. Hamilton MS, Ball J, Bromidge E, Franklin IM: Surface antigen expression of human neoplastic plasma cells includes molecules associated with lymphocyte recirculation and adhesion. Br J Haematol 78:60, 1991
8. Kalasz V, Pap T, Csanaky G, Kelenyi G: Endothelial cell receptors on leukemic plasma cells. Leuk Res 13:863, 1989
9. Kawano MM, Huang N, Harada H, Harada Y, Sakai A, Tanaka H, Iwato K, Kuramoto A: Identification of immature and mature myeloma cells in the bone marrow of human myelomas. Blood 82:564, 1993
10. Kim I, Uchiyama H, Chauhan D, Anderson KC: Cell surface expression and functional significance of adhesion molecules on human myeloma-derived cell lines. Br J Haematol 87:483, 1994
11. Masellis-Smith A, Belch AR, Mant MJ, Turley EA, Pilarski LM: Hyaluron-dependent motility of B cells and leukemic plasma cells in blood, but not of bone marrow plasma cells, in multiple myeloma: Alternate use of receptor for hyaluronan-mediated motility (RHAMM) and CD44. Blood 87:1891, 1996
12. Pellet-Deceunynck C, Barille S, Puthier D, Rapp MJ, Harousseau JL, Bataille R, Amiot M: Adhesion molecules on human myeloma cells: Significant changes in expression related to malignancy, tumor spreading and immortalization. Cancer Res 55:3647, 1995
13. Ridley RC, Xiao H, Hata H, Woodliff J, Epstein J, Sanderson RD: Expression of syndecan regulates human myeloma plasma cell adhesion to type I collagen. Blood 81:767, 1993
14. Smith SR, Auerbach B, Morgan L: Serum neural cell adhesion molecule in multiple myeloma and other plasma cell disorders. Br J Haematol 92:67, 1996
15. Lokhorst HM, Lamme T, de Smet M, Klein S, de Weger RA, van Oers R, Bloem AC: Primary tumor cells of myeloma patients induce interleukin-6 secretion in long-term bone marrow cultures. Blood 84:2269, 1994
16. van Riet I, Bakkus M, De Greef C, Paid L, van Camp B: Homing mechanisms in the etiopathogenesis of multiple myeloma. Stem Cells 13:22, 1995 (suppl 2)
17. Vidriales MB, Anderson KC: Adhesion of multiple myeloma cells to the bone marrow microenvironment: Implications for future therapeutic strategies. Mol Med Today 2:405, 1996
18. Teoh G, Anderson KC: Interaction of tumor and host cells with adhesion and extracellular matrix molecules in the development of multiple myeloma. Hematol Oncol Clin North Am 11:27, 1997
19. Feo-Zuppardi FJ, Taylor CW, Lopez MHA, Grogan TM, Odeleye AO, Hersh EM, Salmon SE: Long-term engraftment of fresh human myeloma cells in SCID mice. Blood 80:2843, 1992
20. Huang Y-W, Richardson JA, Tong AW, Zhang B-Q, Stone MJ, Vitetta ES: Disseminated growth of a human multiple myeloma cell line in mice with severe combined immunodeficiency disease. Cancer Res 53:1392, 1993
21. Huang Y-W, Richardson JA, Vitetta ES: Anti-CD54 (ICAM-1) has antitumor activity in SCID mice with human myeloma cells. Cancer Res 55:610, 1995
22. Alsina M, Boyce B, Devlin RD, Anderson JL, Craig F, Mundy GR, Roodman GD: Development of an in vivo model of human multiple myeloma bone disease. Blood 87:1495, 1996
23. Ahsmann EJM, van Tol MJD, Oudeman-Gruber J, Lokhorst H, Uytdehaag FGCM, Schuurman H-J, Bloem AC: The SCID mouse as a model for multiple myeloma. Br J Haematol 89:319, 1995
24. Klein B, Zhang XG, Lu ZY, Bataille R: Interleukin-6 in human multiple myeloma Blood 85:863, 1995
25. Lichtenstein A, Tu Y, Fady C, Vescio R, Berenson J: Interleukin-6 inhibits apoptosis of malignant plasma cells. Cell Immunol 162:248, 1995
26. Kawano MM, Mihara K, Huang N, Tsujimoto T, Kuramoto A: Differentiation of early plasma cells on bone marrow stromal cells requires interleukin-6 for escaping from apoptosis. Blood 85:487, 1995
27. Hata H, Matsuzaki H, Takeya M, Yoshida M, Sonoki T, Nagasaki A, Kuribayashi N, Kawano F, Takatsuki K: Expression of Fas/Apo-1 (CD95) and apoptosis in tumor cells from patients with plasma cell disorders. Blood 86:1939, 1995
28. Chauhan D, Kharbanda S, Ogata A, Urashima M, Teoh G, Robertson M, Kufe DW, Anderson KC: Interleukin-6 inhibits Fas-induced apoptosis and SAP kinase activation in multiple myeloma cells. Blood 89:227, 1997
29. Urashima M, Chauhan D, Uchiyama H, Freeman GJ, Anderson KC: CD40 ligand triggered interleukin-6 secretion in multiple myeloma. Blood 85:1903, 1995
30. Urashima M, Ogata A, Chauhan D, Hatziyanni M, Vidriales MB, Dedera DA, Schlossman RL, Anderson KC: Transforming growth factor β1: Differential effects on multiple myeloma versus normal B cells. Blood 87:1928, 1996
31. Ohno S, Babonits M, Wiener F, Spira J, Klein G, Potter M: Nonrandom chromosome changes involving the Ig gene-carrying chromosome 12 and 6 in pristane-induced mouse. Cell 18:1001, 1979
32. Suematsu S, Matsuda T, Aozasa K, Akira S, Nakao N, Ohno S, Miyazaki J, Yamamura K, Hirano T, Kishimoto T: IgG1 plasmacytosis in interleukin 6 transgenic mice. Proc Natl Acad Sci USA 86:7547, 1989
33. Suematsu S, Matsusaka T, Matsuda T, Ohno S, Miyazaki J, Yamamura K, Hirano T, Kishimoto T: Generation of plasmacytomas with the chromosomal translocation t(12; 15) in interleukin-6 transgenic mice. Proc Natl Acad Sci USA 89:232, 1994
34. Dedera DA, Urashima M, Chauhan D, LeBrun DP, Bronson R, Anderson KC: Interleukin-6 is required for pristane-induced plasma cell hyperplasia in mice. Br J Haematol 94:53, 1996
35. Hilbert DM, Kopf M, Mock BA, Kohler G, Rudikoff S: Interleukin-6 is essential for in vivo development of B lineage neoplasms. J Exp Med 182:243, 1995
36. McCune JM, Namikawa R, Kaneshima H, Shultz LD, Lieberman M, Weissman IL: The SCID-hu mouse; a model for the analysis of human hematolymphoid differentiation and function. Science 241:1632, 1988
37. Namikawa R, Ueda R, Kyoizumi S: Growth of human myeloid leukemias in the human marrow environment of SCID-hu mice. Blood 82:2526, 1993
38. Kyoizumi S, Murray LJ, Namikawa R: Preclinical analysis of cytokine therapy in the SCID-hu mouse. Blood 81:1479, 1993
39. Akkina RK, Rosenblatt JD, Cambell AG, Chen ISY, Zack JA: Modeling human lymphoid precursor cell gene therapy in the SCID-hu mouse. Blood 84:1393, 1994
40. Namikawa R, Ueda R, Kyoizumi S: Growth of human myeloid leukemias in the human marrow environment of SCID-hu mice. Blood 82:2526, 1993
41. Chen BP, Galy A, Kyoizumi S, Namikawa R, Scarborough J, Webb S, Ford B, Cen DZ, Chen S: Engraftment of human hematopoietic precursor cells with secondary transfer potential in SCID-hu mice. Blood 84:2497, 1994
42. Sandhu JS, Clark BR, Boynton EL, Atkins H, Messner H, Keating A, Hozumi N: Human hematopoiesis in SCID mice implanted with human adult cancellous bone. Blood 88:1973, 1996
43. Barut B, Zon LI, Cochran MK, Paul SR, Chauhan D, Mohrbacher A, Fingeroth J, Anderson KC: Role of interleukin 6 in the growth of myeloma-derived cell lines. Leuk Res 16:951, 1992
44. Hitzler J, Martinez-Valdez H, Bergsagel D, Minden MD: Role of interleukin-6 in the proliferation of human multiple myeloma cell lines OCI-MY1-7 established from patients with advanced stage of the disease. Blood 78:1996, 1991
45. Pinkus GS, Said JW: Specific identification of intracellular immunoglobulin in paraffin sections of multiple myeloma and macroglobulinemia using an immunoperoxidase technique. Am J Pathol 87:47, 1977
46. Urashima M, Chauhan D, Hatzianni M, Ogata A, Hollenbaugh D, Aruffo A, Anderson KC: CD40 ligand triggers interleukin-6-mediated B cell differentiation. Leuk Res 20:507, 1996
47. Hesselton RM, Koup RA, Cromwell MA, Graham BS, Johns M, Sullivan JL: Human peripheral blood xenografts in the SCID mouse: Characterization of immunologic reconstitution. J Infect Dis 168:630, 1993
48. Bellamy WT, Odeleye A, Finley P, Hizenga B, Dalton WS, Weinstein RS, Hersh EM, Grogan TM: An in vivo model of human multidrug-resistant multiple myeloma in SCID mice. Am J Pathol 142:691, 1993
49. Dilber MS, Abedi MR, Bjorkstrand B, Christensson B, Gahrton G, Xanthopoulos KG, Smith CIE: Suicide gene therapy for plasma cell tumors. Blood 88:2192, 1996
50. Guerne PA, Carson DA, Lotz M: IL-6 production by human articular chondrocytes. Modulation of its synthesis by cytokines, growth factors, and hormones in vitro. J Immunol 144:499, 1990
51. 2MDP-liposome-mediated macrophage depletion. Blood 86:183, 1995
52. Solomon A, Weiss DT, Kattine AA: Nephrotoxic potential of Bence Jones proteins. N Engl J Med 324:1845, 1991
53. Fattori E, Della Rocca C, Costa P, Giorgio M, Dente B, Pozzi L, Ciliberto G: Development of progressive kidney damage and myeloma kidney in interleukin-6 transgenic mice. Blood 83:2570, 1994